Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression.

Hypoxia is known to reduce the expression of hepcidin, the master regulator of iron metabolism. However, it is not clear whether this response is primarily related to increased erythropoiesis driven by hypoxically stimulated erythropoietin or to a more direct effect of hypoxia on hepcidin expression. The germline loss-of-function VHL(R200W) mutation is common in Chuvashia, Russia, and also occurs elsewhere. VHL(R200W) homozygotes have elevated hypoxia-inducible factor 1α (HIF-1α) and HIF-2α levels, increased red cell mass, propensity to thrombosis, and early mortality. Ninety VHL(R200W) homozygotes and 52 controls with normal VHL alleles from Chuvashia, Russia, were studied under basal circumstances. In univariate analyses, serum hepcidin concentration was correlated positively with serum ferritin concentration and negatively with homozygosity for VHL(R200W). After adjustment for serum erythropoietin and ferritin concentrations by multiple linear regression, the geometric mean (95% confidence interval of mean) hepcidin concentration was 8.1 (6.3-10.5) ng/mL in VHL(R200W) homozygotes versus 26.9 (18.6-38.0) ng/mL in controls (P < .001). In contrast, a significant independent relationship of serum erythropoietin, hemoglobin, or RBC count with hepcidin was not observed. In conclusion, up-regulation of the hypoxic response leads to decreased expression of hepcidin that may be independent of increased erythropoietin levels and increased RBC counts.

[1]  Paolo Ventura,et al.  Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)‐SMAD signaling pathway in mice , 2011, Hepatology.

[2]  T. Ganz,et al.  Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice , 2011, Hepatology.

[3]  P. Ratcliffe,et al.  Regulation of Type II Transmembrane Serine Proteinase TMPRSS6 by Hypoxia-inducible Factors , 2010, The Journal of Biological Chemistry.

[4]  W. Kaelin,et al.  Reactivation of Hepatic EPO Synthesis in Mice After PHD Loss , 2010, Science.

[5]  Matthias W. Hentze,et al.  Two to Tango: Regulation of Mammalian Iron Metabolism , 2010, Cell.

[6]  D. Gale,et al.  Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin , 2010, Haematologica.

[7]  T. Ganz,et al.  The Role of Hepcidin in Iron Metabolism , 2009, Acta Haematologica.

[8]  Y. T. Lee,et al.  Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. , 2009, Blood.

[9]  Manuela M. Santos,et al.  Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. , 2009, Blood.

[10]  G. Semenza.  Regulation of oxygen homeostasis by hypoxia-inducible factor 1. , 2009, Physiology.

[11]  Tatiana Ammosova,et al.  Altered cytokine profiles in patients with Chuvash polycythemia , 2009, American journal of hematology.

[12]  L. Silvestri,et al.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. , 2008, Cell metabolism.

[13]  D. Girelli,et al.  Immunoassay for human serum hepcidin. , 2008, Blood.

[14]  C. Beaumont,et al.  Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia , 2008, Critical care medicine.

[15]  W. Kaelin,et al.  Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. , 2008, Molecular cell.

[16]  Kai-Uwe Eckardt,et al.  Epidermal Sensing of Oxygen Is Essential for Systemic Hypoxic Response , 2008, Cell.

[17]  F. Carvalho,et al.  Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPα , 2008, Blood.

[18]  Tatiana Ammosova,et al.  Elevated homocysteine, glutathione and cysteinylglycine concentrations in patients homozygous for the Chuvash polycythemia VHL mutation , 2008, Haematologica.

[19]  W. Rathmell,et al.  von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis. , 2007, The Journal of clinical investigation.

[20]  S. Goh,et al.  High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin , 2007, Nature Medicine.

[21]  V. Nizet,et al.  Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). , 2007, The Journal of clinical investigation.

[22]  W. Jelkmann,et al.  Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-alpha hydroxylases. , 2007, Current medicinal chemistry.

[23]  U. Merle,et al.  Regulation of hepcidin in HepG2 and RINm5F cells , 2007, Peptides.

[24]  T. Ganz,et al.  Suppression of hepcidin during anemia requires erythropoietic activity. , 2006, Blood.

[25]  H. Cario.  Childhood polycythemias/erythrocytoses: classification, diagnosis, clinical presentation, and treatment , 2005, Annals of Hematology.

[26]  G. Semenza,et al.  Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. , 2005, Blood.

[27]  Jerry Kaplan,et al.  Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization , 2004, Science.

[28]  A. M. Giannetti,et al.  HFE and Transferrin Directly Compete for Transferrin Receptor in Solution and at the Cell Surface* , 2004, Journal of Biological Chemistry.

[29]  P. Choyke,et al.  Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. , 2004, Blood.

[30]  Elizabeta Nemeth,et al.  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. , 2004, The Journal of clinical investigation.

[31]  S. Shete,et al.  The worldwide distribution of the VHL 598C>T mutation indicates a single founding event. , 2004, Blood.

[32]  M. McMullin,et al.  Chuvash-type congenital polycythemia in 4 families of Asian and Western European ancestry. , 2003, Blood.

[33]  W. Kaelin,et al.  HIF hydroxylation and the mammalian oxygen-sensing pathway. , 2003, The Journal of clinical investigation.

[34]  David Mole,et al.  Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia , 2002, Nature Genetics.

[35]  Gaël Nicolas,et al.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. , 2002, The Journal of clinical investigation.

[36]  Michael I. Wilson,et al.  C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.

[37]  Poliakova La.  Familial erythrocytosis among the residents of the Chuvash ASSR , 1974 .

[38]  P. Ramos,et al.  erythropoiesis in Decreased differentiation of erythroid cells exacerbates ineffective , 2008 .

[39]  P. Robbins,et al.  Mutation of the von Hippel-Lindau gene alters human cardiopulmonary physiology. , 2008, Advances in experimental medicine and biology.

[40]  E. Nečas,et al.  Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. , 2006, Physiological research.

[41]  S. Nekhai,et al.  Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia. , 2006, Haematologica.

[42]  D. Stockton,et al.  Congenital polycythemias/erythrocytoses. , 2005, Haematologica.

[43]  D. Stockton,et al.  Endemic polycythemia in Russia: mutation in the VHL gene. , 2002, Blood cells, molecules & diseases.

[44]  Thomas G. Smith,et al.  Competing Interests: PHM, CWP, , 2022 .